For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
World Inflammatory Bowel Disease Day 2025: IBD has no borders
+Practice
Nutrition
World Inflammatory Bowel Disease Day 2025: IBD has no borders
Friday 16 May 2025, 12:25 AM

World Inflammatory Bowel Disease Day 2025 aims to improve health outcomes by encouraging people to speak openly about IBD [Image: European Federation of Crohn’s & Ulcerative Colitis Associations]
Dietitian Catherine Wall looks at inflammatory bowel disease, how it impacts diet and eating habits, and why it is important to add new foods to the diet, rather than exclude them
Key points, Inflammatory bowel disease can affect anyone, and its prevalence is increasing.
IBD can present with highly variable symptoms, including const, Pract Green w Pale Yellow
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.
References
1. Morton H, Coad J, Pedley KC, Irwin JR. Incidence of inflammatory bowel disease in New Zealand remains high, findings in the Manawatū region. Dig Dis Sci 2023;68(11):4230–42.
2. Seleq S, Weilert F, Fulforth J. Inflammatory bowel disease in Waikato, New Zealand: incidence and prevalence. Intern Med J 2023;53(12):2307–12.